JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Gross-Profit-to-Asset % : 12.78% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. JSP Pharmaceutical Manufacturing (Thailand) PCL's annualized Gross Profit for the quarter that ended in Mar. 2024 was ฿173.07 Mil. JSP Pharmaceutical Manufacturing (Thailand) PCL's average Total Assets over the quarter that ended in Mar. 2024 was ฿1,353.69 Mil. Therefore, JSP Pharmaceutical Manufacturing (Thailand) PCL's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 12.78%.

JSP Pharmaceutical Manufacturing (Thailand) PCL Gross-Profit-to-Asset % Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Gross-Profit-to-Asset % Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

25.22

31.45

16.55

11.04

10.69

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial										10.35	5.75	12.47	13.65	12.78

Competitive Comparison of JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross-Profit-to-Asset %

For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross-Profit-to-Asset % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross-Profit-to-Asset % falls into.

JSP Pharmaceutical Manufacturing (Thailand) PCL Gross-Profit-to-Asset % Calculation

JSP Pharmaceutical Manufacturing (Thailand) PCL's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	144.475	/	( (1366.512	+	1335.675)	/ 2 )
	=	144.475	/	1351.0935
	=	10.69 %

JSP Pharmaceutical Manufacturing (Thailand) PCL's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	173.068	/	( (1335.675	+	1371.711)	/ 2 )
	=	173.068	/	1353.693
	=	12.78 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

JSP Pharmaceutical Manufacturing (Thailand) PCL Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120

Website

https://www.jsppharma.com

JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines